Next Generation Antibody Therapies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Researchmoz added Most up-to-date research on "Next Generation Antibody Therapies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.

Antibodies are potent biopharmaceutical agents designed to target specific cells. Many researchers have concentrated their efforts to develop antibodies specific to the antigens present on cancer cells. Research and development in the field of antibodies is progressing rapidly. In the past 25 years, over 30 immunoglobulins (IgGs) and their derivatives have been approved for various indications. The currently approved antibody drugs are used not only to treat diseases that affect large number of patients (such as inflammatory diseases and cancer), but also for indications that require special regulatory procedures.

Antibody production has attracted researchers across the world owing to several advantages such as wider therapeutic window, high efficacy to treat certain diseases, and easy development process. Due to these advantages, the global next generation antibody therapies market is experiencing impressive growth. Research and development is also being carried out to create antibody fragments that only bind and neutralize the target, but do not provoke any immune response in contrast to the full length antibody. Moreover, high number of studies are performed in the area of bispecific antibodies that bind to two different targets.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1380602

The global next generation antibody therapies market can be segmented based on type of antibody, application, end-user, and region. In terms of type of antibody, the market can be categorized into antibody-drug conjugates (ADCs), bispecific antibodies, intrabodies, alternative protein scaffold, antibody fragments and single domain antibodies, antibody with modified Fc functions (engineered antibodies), and others. Based on application, the global next generation antibody therapies market can be divided into oncology, autoimmune diseases, and others. In terms of region, the market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The global next generation antibody therapies market is expected to register double digit growth rate owing to increasing efforts by the pharmaceutical and biotechnology companies and research laboratories to develop new antibodies that can treat major diseases such as cancer, rheumatoid arthritis, and other chronic diseases. Additionally, large number of antibody drug conjugates under clinical study is likely to boost market growth in the near future. However, small number of commercially available antibody drug conjugates and high cost limit the uptake of these drugs. This in turn restrains the market. Moreover, stringent government regulations such as those imposed by the U.S. FDA and high cost of production of antibodies are anticipated to hamper the growth of the global next generation antibody therapies market.

Browse Detail Report With TOC @ https://www.researchmoz.us/next-generation-antibody-therapies-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html

North America dominates the global next generation antibody therapies market. Growth of the market in North America is attributed to increasing research and development on antibodies by pharmaceutical and biotechnology companies. Europe is considered to be the second largest market for next generation antibody therapies owing to the strong presence of biotechnology and pharmaceutical companies in the region. Countries in Asia Pacific such as India and China are the emerging markets for next generation antibody production due to rising prevalence of cancer and other chronic diseases, and large population base for conducting clinical trials. Additionally, large number of R&D activities in the region and cost efficient research services contribute to the growth of the market in Asia Pacific
.
Major players competing in the global next generation antibody therapies market are Amgen, Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Bayer AG, F. Hoffmann-La Roche Ltd., Genmab A/S, Kyowa Hakko Kirin Co. Ltd., ImmunoGen, Inc., Pfizer, Inc., Seattle Genetics, Inc. and Xencor, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

This release was published on openPR.